Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience.
Mateusz OgledzinskiPiotr J BachulKourosh RezaniaSeenu M HariprasadSarah GondekWilliam LinBraden JuengelKamila MilejczykLindsay BastoLing-Jia WangLaurencia PereaMartin TibudanRolf N BarthJohn J FungPiotr WitkowskiPublished in: Clinical transplantation (2023)